[go: up one dir, main page]

Subr et al., 1989 - Google Patents

Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds

Subr et al., 1989

Document ID
2381070850712976007
Author
Subr V
Duncan R
Kopecek J
Publication year
Publication venue
Journal of Biomaterials Science, Polymer Edition

External Links

Snippet

The synthesis of hydrophilic gels based on N (2-hydroxypropyl) methacrylamide copolymers crosslinked via degradable oligopeptide sequences is described. The influence of the conditions of preparation and of the gel structure on the equilibrium degree of swelling …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48176—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48784—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being semi-solid, an ointment, a gel, a hydrogel, a solidifying gel

Similar Documents

Publication Publication Date Title
Subr et al. Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds
Chiu et al. Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system
Ulbrich et al. Polymers containing enzymatically degradable bonds. VI. Hydrophilic gels cleavable by chymotrypsin
Chan et al. Polypeptoid polymers: Synthesis, characterization, and properties
Kopeček Controlled biodegradability of polymers—a key to drug delivery systems
EP0187547B1 (en) Synthetic polymeric drugs
Okada Molecular design and syntheses of glycopolymers
Ulbrich et al. Poly (ethylene glycol) s containing enzymatically degradable bonds
Ulbrich et al. Synthesis of novel hydrolytically degradable hydrogels for controlled drug release
Ghandehari et al. In vitro degradation of pH-sensitive hydrogels containing aromatic azo bonds
Ooya et al. Synthesis and characterization of biodegradable polyrotaxane as a novel supramolecular-structured drug carrier
EP0359996A2 (en) Synthetic amino acid-and/or peptide-containing graft copolymers
Ulbrich et al. Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papain
Yeh et al. Biodegradable and pH‐sensitive hydrogels: Synthesis by crosslinking of N, N‐dimethylacrylamide copolymer precursors
JPH09506012A (en) Multifunctional organic polymer
JPH05508879A (en) Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
Nathan et al. Hydrogels based on water-soluble poly (ether urethanes) derived from L-lysine and poly (ethylene glycol)
Chiu et al. Enzymic activity of chymotrypsin and its poly (ethylene glycol) conjugates toward low and high molecular weight substrates
Ghandehari et al. Biodegradable and pH sensitive hydrogels: synthesis by a polymer‐polymer reaction
Gerrits et al. Semiflexible polymer scaffolds: an overview of conjugation strategies
Yeh et al. Degradability of hydrogels containing azoaromatic crosslinks
Sedlačík et al. Enzymatic degradation of the hydrogels based on synthetic poly (α-amino acid) s
US20050276858A1 (en) Bifunctional-modified hydrogels
De Marre et al. Evaluation of the hydrolytic and enzymatic stability of macromolecular Mitomycin C derivatives
Šubr et al. Degradation of oligopeptide sequences connecting poly [N-(2-hydroxypropyl) methacrylamide] chains by lysosomal cysteine proteinases